Filter Results:
(557)
Show Results For
- All HBS Web
(557)
- People (4)
- News (149)
- Research (350)
- Events (2)
- Multimedia (4)
- Faculty Publications (168)
Show Results For
- All HBS Web
(557)
- People (4)
- News (149)
- Research (350)
- Events (2)
- Multimedia (4)
- Faculty Publications (168)
- 04 Sep 2019
- News
Deep Dive
manage a worldwide team to develop a virtual product—diving to the bottom of all five oceans, and doing a lot of science along the way.” The Five Deeps Expedition, Vescovo said, has “proven to be as challenging as any business thing I’ve... View Details
- 07 Aug 2000
- Research & Ideas
The Business of Biotech
developments suggest that doctors will eventually be able to treat patients more effectively with medicine tailored to their genetic makeup, including, in some cases, gene replacement therapies. "The View Details
- 25 Apr 2005
- Research & Ideas
New Learning at American Home Products
pharmaceuticals, it concentrated on enlarging its OTC business by, as before, exploiting its advertising skills. By 1979 it had developed a broader line of new prescription drugs, beginning in 1968 with Inderal, a beta-blocker View Details
- 01 Jun 2018
- News
Floor It
leading from the street to the house itself. That insight, coupled with the radical nature of precision medicine, led to a realization: A “business as usual” approach wouldn’t do the trick; a different way of fighting cancer required an equally innovative approach to... View Details
Keywords: Julia Hanna; illustration by Mengxin Li
Josiah K. Lilly
Lilly, a trained pharmacist and the founder of the family drug manufacturer, set up the first scientific division in the company and focused on standards of manufacturing and scientific development. Among other products, the company... View Details
Keywords: Healthcare
- 04 Sep 2019
- News
Accelerating Scientific Discovery
development of a course that could enhance decision making by providing participants with the knowledge and skills to better manage, fund, and commercialize scientific discoveries that could potentially cure illnesses ranging from... View Details
Keywords: Jennifer Gillespie
- 18 Jun 2001
- Research & Ideas
When In-House Research Isn’t Enough
For many decades, corporate research and development has been pretty much an "inside job." The road to innovative new products and services began and ended with a company's internal R&D. But according to HBS assistant... View Details
Keywords: by Jim Aisner
- 07 Oct 2014
- News
Network Effect
was shocked by their advice. “They said, ‘Try three Advil a day. It might help. There are a few FDA-approved drugs for Alzheimer’s disease, and they won’t help,’” he recalls. McCance, a venture- capital pioneer with Greylock Partners, had... View Details
Keywords: Linda Kush
- Fast Answer
Biotech and Pharmaceuticals: R&D spending, production cost
can be found in company’s income statement that can be found in Capital IQ ABI/ProQuest - To locate articles on the topic, use search terms: drug development cost (drug development) AND (success... View Details
- 11 Aug 2003
- Research & Ideas
Cheap, Fast, and In Control: How Tech Aids Innovation
product and service development is changing; creating the potential for higher R&D performance, innovation, and value creation for customers. The choice is simple: Organizations can either ignore these changes or take action and tap... View Details
Keywords: by Wendy Guild
- 23 Mar 2003
- Research & Ideas
AIDS in Africa—What’s the Solution?
teachers to talk about AIDS prevention, the government can use a built-in educational infrastructure. Ngozi Edozien Ngozi Edozien, vice president of PPG Planning and Business Development for Pfizer, said the lack of a delivery... View Details
Keywords: by Julie Jette
- Student-Profile
Olivia Zhao
pros and cons of a public system facing increased privatization. Research Olivia’s research hones in on the pharmaceutical industry and looking at the lifecycle of a drug. “It starts, of course, with research and development at huge View Details
Ernest H. Volwiler
Volwiler was a pioneer in the field of anesthetic medicine, developing two breakthrough drugs, Nembutal and Pentothal, which put patients to sleep for surgical or dental procedures. Beyond his brilliance as a scientist, Volwiler was... View Details
Keywords: Healthcare
- Web
Esther Koh | MBA
Tech Fellow, I can gain the strong foundation necessary to launch such ventures in a dynamic biotech environment alongside fellow builders on campus. Tech areas of interest: Biotech, medical devices, biomaterials, drug design and... View Details
- 01 Sep 2008
- News
In Africa, Porter Sees Lessons for Health Care
delivery systems of both developing and advanced countries: fragmentation, inefficiency, and organization around discrete interventions (such as delivering drugs or screening) rather than integrated care.... View Details
- 24 Apr 2014
- News
Finding a cure so that others may benefit
call. The foundation wanted to invest in for-profit bioscience companies to spur scientists to find a cure for the disease. O’Donnell is credited with almost singlehandedly raising $250 million in support of this venture philanthropy, which led to the View Details
Richard M. Furlaud
Furlaud focused on Squibb's pharmaceuticals, investing in research and development that ultimately led to the introduction of several new drugs. Furlaud's streamlining and consistent support of the company's cardiovascular View Details
Keywords: Healthcare
- Web
Consumer Information | MBA
Disabilities Career and Professional Development Drug and Alcohol Prevention Retention and Graduation Rates Campus Security Fire Safety Student Records Policy (FERPA) University Wide Consumer Information View Details
- 13 Jan 2003
- Research & Ideas
Making Biotech Work as a Business
technologies for drug discovery.) And patients with previously unmet medical needs can now get treatments that were not available before. That should be inspiring, he reminded the audience. Economic frustrations remain, however. Pisano... View Details
- 01 Sep 2011
- News
Alumni Team Up to Fight Cancer
networking among its alumni community. Bowes, founding partner of US Venture Partners, and Giusti, founder of the Multiple Myeloma Research Foundation (MMRF), discussed the need for innovative, results-oriented biomedical research and View Details